IGFBP2 and glioma: While genomic studies have strongly suggested the expression of IGFBP2 to be used as a bad prognosis factor in glioma, our studies support for the first time, at least to our knowledge, the need to analyze the cleavage of IGFBP2 protein in human glioma specimens.